Back to 
Baillie Gifford & Co.
Baillie Gifford & Co.
STRO
Showing 3 of 20 quarters
Position history for Baillie Gifford & Co.'s holdings in Sutro Biopharma, Inc.
No. Baillie Gifford exited its STRO (Sutro Biopharma) position in Q1 2025. Its Q4 2024 13F listed 48,791 shares worth $89,775. Baillie Gifford first reported STRO in Q2 2020 and held it in 19 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$5.3M
Total Shares Change
-1.5M
Quarter-by-Quarter History
Other major holders of STRO: Franklin Templeton Inc., State Street Corp.